Navigation Links
Fibers in Semen Help HIV Penetrate Cells

The chances of infection are boosted 50-fold to 100,000-fold, study finds

THURSDAY, Dec. 13 (HealthDay News) -- In a discovery that perplexes HIV experts, an international team reports that tiny fibers commonly found in semen drastically enhance the ability of the virus to do its damage.

According to a study in the Dec. 14 issue of Cell, the fibers capture the virus and then ferry it to target cells, increasing its ability to infect someone by more than 50 times in some cases and more than 100,000 times in others.

The findings could help scientists better understand how AIDS is transmitted. But Rowena Johnston, director of research with the Foundation for AIDS Research (amfAR), noted that the value of the research is limited, because it doesn't "necessarily reflect transmission in the 'real world.' "

"This is intriguing, and it's worth further investigation," said Johnston. "But there's nothing yet that makes me have a 'Eureka' moment."

While scientists have long known about the basics of AIDS transmission, it's not clear why the virus travels more easily through some routes than others.

For example, male-to-female sexual transmission is usually more common than the other way around but not always. And it's also not clear why the virus has become so prevalent even though it has a tiny presence in blood.

In the new study, led by a German team, scientists tried to figure out if components of human semen might affect transmission of the AIDS virus.

"We were not expecting to find an enhancer and were even more surprised about the strength," study author Dr. Frank Kirchhoff, of the University Clinic of Ulm, said in a statement. "Most enhancers have maybe a two- or threefold effect, but here, the effect was amazing, more than 50-fold, and, under certain conditions, more than 100,000-fold. At first, I didn't believe it, but we ran the experiment over and over, always with the same result."

Dr. Jeffrey Laurence, a professor of medicine and director of the Laboratory for AIDS Virus Research at Weill Medical College of Cornell University, said there could be something similar at play in cervical fluid that affects transmission. "In a lot of situations in the real world, women transmit HIV quite easily...," Laurence said.

He added that many other factors affect transmission of HIV, from bodily abrasions to menstrual cycles and use of oral contraceptives.

Could this latest finding bring scientists closer to an AIDS vaccine? Laurence, who thinks a vaccine is decades off, is doubtful. Prevention, however, might be another matter.

Laurence said it might be possible to develop an "antidote" for the virus-boosting powers of semen and put it in a microbicide that people could use before sex.

More information

Learn more about the basics of AIDS from

SOURCES: Jeffrey Laurence, M.D., professor, medicine, and director, Laboratory for AIDS Virus Research, Weill Medical College of Cornell University, New York City; Rowena Johnston, Ph.D., director, research, Foundation for AIDS Research (amfAR), New York City; Dec. 14, 2007, Cell

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Meth Project Advertisements Selected for National Prevention Campaign
3. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
4. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
5. Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care
6. Patients perceived cancer care unaffected by lower Medicare reimbursements
7. Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
8. Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms
9. Valley Health System Caregivers, Members of SEIU UHW, to Announce Endorsement of Measure G
10. Leading Oncologists from Across the Country Hold Emergency Meeting on New Government Reimbursement Policy for Medicare Patients with Cancer
11. Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer
Post Your Comments:
Related Image:
Fibers in Semen Help HIV Penetrate Cells
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone ... member, close friend, or animal pass away, death lives among us. It is your ... Coming from a family of 11 children, author T Sky understands that she may ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... IL (PRWEB) , ... November 30, 2015 , ... The ... an emerging pharmaceutical company. Because it is so important to this key industry segment, ... Factors in your IND Filing” on December 4th at 11am EST. , Federal law ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... & Laser Center is one of a select few plastic surgeons in the ... non-surgical fat removal. , SculpSure™ is the world’s first heat-induced laser treatment for ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- Booth #4303 – The Imaging Components business of Varian ... array of products in a new booth (#4303) at the ... America in Chicago this ... components "At the Heart of Imaging." Products will include a ... Claymount brand, and computer-aided diagnostic software from MeVis as well ...
(Date:11/30/2015)... -- Hanger, Inc. (NYSE: HGR ) (the "Company") today ... its previously announced consent solicitation (as amended and restated, ... amount 7⅛% Senior Notes due 2018 (the "Notes") to ... pursuant to the Consent Solicitation, (ii) the proposed increased ... date of the Consent Solicitation.    ...
(Date:11/30/2015)... , Nov. 30, 2015   VolitionRx Limited (NYSE ... diagnostic tests for a broad range of cancer types and ... LD Micro Conference, which will be held December 1 - 3 ... from VolitionRx will be David Kratochvil , Chief Financial ... of Investor Relations. ® blood-based tests for ...
Breaking Medicine Technology: